Ultragenyx Pharmaceutical
RARE
#4102
Rank
โ‚น227.71 B
Marketcap
โ‚น2,409
Share price
0.18%
Change (1 day)
-36.42%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Net assets

Net assets on the balance sheet as of March 2025 : โ‚น13.17 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company has โ‚น13.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ultragenyx Pharmaceutical - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น22.50 B-1.86%
2023-12-31$โ‚น22.92 B-21.4%
2022-12-31$โ‚น29.16 B-57.52%
2021-12-31$โ‚น68.66 B-18.66%
2020-12-31$โ‚น84.42 B81.09%
2019-12-31$โ‚น46.62 B9.5%
2018-12-31$โ‚น42.57 B73.9%
2017-12-31$โ‚น24.48 B-23.98%
2016-12-31$โ‚น32.20 B-8.74%
2015-12-31$โ‚น35.29 B201.1%
2014-12-31$โ‚น11.72 B278.63%
2013-12-31$โ‚น3.09 B-32.96%
2012-12-31$โ‚น4.61 B720.2%
2011-12-31$โ‚น0.56 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น504.49 B 3,730.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น16.85 B 27.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น37.12 Billion-381.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น10.71 B-18.65%๐Ÿ‡บ๐Ÿ‡ธ USA